These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 36860852)

  • 1. Heterologous prime-boost cellular vaccination induces potent antitumor immunity against triple negative breast cancer.
    Niavarani SR; St-Cyr G; Daniel L; Lawson C; Giguère H; Alkayyal AA; Tai LH
    Front Immunol; 2023; 14():1098344. PubMed ID: 36860852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personalized neoantigen viro-immunotherapy platform for triple-negative breast cancer.
    Brito Baleeiro R; Liu P; Chard Dunmall LS; Di Gioia C; Nagano A; Cutmore L; Wang J; Chelala C; Nyambura LW; Walden P; Lemoine N; Wang Y
    J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37586771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer.
    Huang L; Rong Y; Tang X; Yi K; Qi P; Hou J; Liu W; He Y; Gao X; Yuan C; Wang F
    Mol Cancer; 2022 Feb; 21(1):45. PubMed ID: 35148751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncolytic poxvirus CF33-hNIS-ΔF14.5 favorably modulates tumor immune microenvironment and works synergistically with anti-PD-L1 antibody in a triple-negative breast cancer model.
    Chaurasiya S; Yang A; Kang S; Lu J; Kim SI; Park AK; Sivanandam V; Zhang Z; Woo Y; Warner SG; Fong Y
    Oncoimmunology; 2020; 9(1):1729300. PubMed ID: 32158622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4
    Xiao M; Xie L; Cao G; Lei S; Wang P; Wei Z; Luo Y; Fang J; Yang X; Huang Q; Xu L; Guo J; Wen S; Wang Z; Wu Q; Tang J; Wang L; Chen X; Chen C; Zhang Y; Yao W; Ye J; He R; Huang J; Ye L
    J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35580929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterologous prime-boost immunization co-targeting dual antigens inhibit tumor growth and relapse.
    Guo Q; Wang L; Xu P; Geng F; Guo J; Dong L; Bao X; Zhou Y; Feng M; Wu J; Wu H; Yu B; Zhang H; Yu X; Kong W
    Oncoimmunology; 2020 Nov; 9(1):1841392. PubMed ID: 33224629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting myeloid-derived suppressor cells in combination with tumor cell vaccination predicts anti-tumor immunity and breast cancer dormancy: an in silico experiment.
    Mehdizadeh R; Shariatpanahi SP; Goliaei B; Rüegg C
    Sci Rep; 2023 Apr; 13(1):5875. PubMed ID: 37041172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Celecoxib Augments Paclitaxel-Induced Immunogenic Cell Death in Triple-Negative Breast Cancer.
    Qian X; Yang H; Ye Z; Gao B; Qian Z; Ding Y; Mao Z; Du Y; Wang W
    ACS Nano; 2024 Jun; 18(24):15864-15877. PubMed ID: 38829727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of pan-cancer/testis genes and validation of therapeutic targeting in triple-negative breast cancer: Lin28a-based and Siglece-based vaccination induces antitumor immunity and inhibits metastasis.
    Carter JA; Matta B; Battaglia J; Somerville C; Harris BD; LaPan M; Atwal GS; Barnes BJ
    J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38135347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hainanenin-1, an oncolytic peptide, triggers immunogenic cell death via STING activation in triple-negative breast cancer.
    Li X; Su N; Yu H; Li X; Sun SL
    Cell Commun Signal; 2024 Jul; 22(1):352. PubMed ID: 38970078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy for Triple-Negative Breast Cancer: Latest Research and Clinical Prospects.
    Ahmed RF; Jameel F; Irfan M
    Crit Rev Immunol; 2019; 39(3):211-221. PubMed ID: 32421965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterologous Prime-Boost Vaccination with a Peptide-Based Vaccine and Viral Vector Reshapes Dendritic Cell, CD4+ and CD8+ T Cell Phenotypes to Improve the Antitumor Therapeutic Effect.
    Hofer T; Rossi M; Carboni S; Di Berardino Besson W; von Laer D; Wollmann G; Derouazi M; Santiago-Raber ML
    Cancers (Basel); 2021 Dec; 13(23):. PubMed ID: 34885215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin improves the therapeutic efficacy of Listeria(at)-Mage-b vaccine in correlation with improved T-cell responses in blood of a triple-negative breast cancer model 4T1.
    Singh M; Ramos I; Asafu-Adjei D; Quispe-Tintaya W; Chandra D; Jahangir A; Zang X; Aggarwal BB; Gravekamp C
    Cancer Med; 2013 Aug; 2(4):571-82. PubMed ID: 24156030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.
    Jiang W; Wang S; Chen H; Ren H; Huang X; Wang G; Chen Z; Chen L; Chen Z; Zhou P
    J Virol; 2017 May; 91(9):. PubMed ID: 28179535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Stapled anoplin peptide combined with photothermal therapy enhances oncolytic immunotherapy of triple-negative breast cancer].
    Gao WD; Liu XX; Yang T; Lin JY; Song YX; Lu SX; Zhang XK; Wu Y; Luan X; Zhang WD
    Zhongguo Zhong Yao Za Zhi; 2023 Sep; 48(18):4981-4992. PubMed ID: 37802840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biotinylated Streptavidin Surface Coating Improves the Efficacy of a PLGA Microparticle-Based Cancer Vaccine.
    Gross BP; Chitphet K; Wongrakpanich A; Wafa EI; Norian LA; Salem AK
    Bioconjug Chem; 2020 Sep; 31(9):2147-2157. PubMed ID: 32786363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress and Prospect of Immunotherapy for Triple-Negative Breast Cancer.
    Luo C; Wang P; He S; Zhu J; Shi Y; Wang J
    Front Oncol; 2022; 12():919072. PubMed ID: 35795050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor membrane-based vaccine immunotherapy in combination with anti-CTLA-4 antibody confers protection against immune checkpoint resistant murine triple-negative breast cancer.
    Pack CD; Bommireddy R; Munoz LE; Patel JM; Bozeman EN; Dey P; Radhakrishnan V; Vartabedian VF; Venkat K; Ramachandiran S; Reddy SJC; Selvaraj P
    Hum Vaccin Immunother; 2020 Dec; 16(12):3184-3193. PubMed ID: 32530786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A marine-derived small molecule induces immunogenic cell death against triple-negative breast cancer through ER stress-CHOP pathway.
    Wen H; Zhong Y; Yin Y; Qin K; Yang L; Li D; Yu W; Yang C; Deng Z; Hong K
    Int J Biol Sci; 2022; 18(7):2898-2913. PubMed ID: 35541893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A modular self-adjuvanting cancer vaccine combined with an oncolytic vaccine induces potent antitumor immunity.
    Das K; Belnoue E; Rossi M; Hofer T; Danklmaier S; Nolden T; Schreiber LM; Angerer K; Kimpel J; Hoegler S; Spiesschaert B; Kenner L; von Laer D; Elbers K; Derouazi M; Wollmann G
    Nat Commun; 2021 Aug; 12(1):5195. PubMed ID: 34465781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.